12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Inhaled Lipid-complexed Cisplatin: Phase II started

Eleison began an open-label, U.S. Phase II trial to evaluate 36 mg/m 2 ILC via nebulization every 2 weeks for up to 1...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >